World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
9322
World Ranking
3500
National Ranking
307

Shiranee Sriskandan publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Shiranee Sriskandan sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 243 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Shiranee Sriskandan D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Shiranee Sriskandan sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Shiranee Sriskandan is affiliated with Imperial College London in the United Kingdom. Their research spans multiple fields including Medicine with a focus on Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology, Molecular Biology, and Molecular Medicine. The volume of publications reflects a broad engagement with topics central to clinical and molecular aspects of infectious diseases.

The scientist's research covers several main topics, including:

  • Streptococcal Infections and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Neonatal and Maternal Infections
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing

Some of their most cited recent papers illustrate involvement in COVID-19 research during the pandemic. These include:

  • "Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study," 2021, published in The Lancet Microbe
  • "Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19," 2021, published in Science Immunology
  • "Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study," 2021, published in The Lancet Respiratory Medicine
  • "Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK," 2021, published in The Lancet Respiratory Medicine
  • "Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study," 2021, published in The Lancet

Frequent co-authors highlight collaborations in infectious disease and clinical research. These include:

  • Peter Openshaw
  • Malcolm G. Semple
  • J. Kenneth Baillie
  • Annemarie B Docherty
  • Mahdad Noursadeghi

Their work is regularly published in key scientific venues. Frequent publication platforms include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Lancet Microbe
  • Nature Communications
  • Microbial Genomics
  • Clinical Infectious Diseases

Best Publications

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • The immunology of sepsis.

    S Sriskandan;DM Altmann

  • Mammalian Toll-like receptors: to immunity and beyond.

    P. A. Hopkins;S. Sriskandan

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

    Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  • GRAM-POSITIVE SEPSIS: Mechanisms and Differences from Gram-Negative Sepsis

    Shiranee Sriskandan;Jonathan Cohen

  • Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.

    Ryan S Thwaites;Ashley Sanchez Sevilla Uruchurtu;Matthew K Siggins;Felicity Liew

  • Specific C-Terminal Cleavage and Inactivation of Interleukin-8 by Invasive Disease Isolates of Streptococcus pyogenes

    Robert J. Edwards;Graham W. Taylor;Melissa Ferguson;Stephen Murray

  • Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study.

    Nicola N Lynskey;Elita Jauneikaite;Elita Jauneikaite;Ho Kwong Li;Xiangyun Zhi

  • The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing

    Annelies S. Zinkernagel;Anjuli M. Timmer;Morgan A. Pence;Jeffrey B. Locke

  • Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.

    Tom Parks;Clare Wilson;Nigel Curtis;Anna Norrby-Teglund

  • Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK.

    Chloe I Bloom;Thomas M Drake;Annemarie B Docherty;Brian J Lipworth

  • Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.

    Thomas M Drake;Aya M Riad;Cameron J Fairfield;Conor Egan

  • The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm

    Lee Faulkner;Anneli Cooper;Cristina Fantino;Daniel M. Altmann

  • Emergence of a New Highly Successful Acapsular Group A Streptococcus Clade of Genotype emm89 in the United Kingdom

    Claire E. Turner;James Abbott;Theresa Lamagni;Matthew T. G. Holden;Matthew T. G. Holden

  • Superantigens and streptococcal toxic shock syndrome

    Thomas Proft;Shiranee Sriskandan;Lily Yang;John D. Fraser

  • Necrotising soft-tissue infections.

    Unknown

  • HLA Class II Polymorphisms Determine Responses to Bacterial Superantigens

    Martin Llewelyn;Shiranee Sriskandan;Mark Peakman;David R. Ambrozak

  • Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic-shock syndrome

    Shiranee Sriskandan;David Moyes;Jonathan Cohen

  • Emerging Role of the Interleukin-8 Cleaving Enzyme SpyCEP in Clinical Streptococcus pyogenes Infection

    Claire E. Turner;Prathiba Kurupati;Michael D. Jones;Robert J. Edwards

  • SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Unknown

  • Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation

    Shiranee Sriskandan;Melissa Ferguson;Victoria Elliot;Lee Faulkner

  • Invasive disease and toxic shock due to zoonotic Streptococcus suis: An emerging infection in the East?

    Shiranee Sriskandan;Josh D Slater

  • Pro-Inflammatory Mechanisms in Sepsis

    Deborah L.W. Chong;Shiranee Sriskandan

Frequent Co-Authors

Daniel M. Altmann
Daniel M. Altmann Imperial College London
Matthew T. G. Holden
Matthew T. G. Holden University of St Andrews
Androulla Efstratiou
Androulla Efstratiou Public Health England
Alison Holmes
Alison Holmes Imperial College London
David L. Moyes
David L. Moyes Imperial College London
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Jonathan Cohen
Jonathan Cohen The University of Texas Southwestern Medical Center
Jane A. Mitchell
Jane A. Mitchell National Institutes of Health
Mahdad Noursadeghi
Mahdad Noursadeghi University College London
Thomas Krausz
Thomas Krausz University of Chicago

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of related online degrees and career pathways that cater to diverse interests and skill sets. For individuals looking for educational opportunities with fewer barriers, exploring degrees felons can get provides valuable insight into accessible programs that can lead to rewarding careers.

For those interested in the healthcare field with a focus on holistic approaches, pursuing functional medicine NP programs can enhance expertise as nurse practitioners specializing in patient-centered care, often complementing microbiology-related knowledge.

Online degrees related to health information and coding offer strong career prospects as well. Becoming a Certified Professional Coder builds expertise in medical coding and billing, supported by competitive salaries as detailed in the certified professional coder salary outline.

Similarly, careers in health data management are growing, with online programs preparing students to manage sensitive health information effectively. The health information manager salary information highlights the earning potential and varied opportunities in this essential healthcare sector.

Best Scientists Citing Shiranee Sriskandan

Trending Scientists

Recently Published Articles